Edition:
United States

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,419JPY
22 Sep 2017
Change (% chg)

¥-26 (-1.80%)
Prev Close
¥1,445
Open
¥1,442
Day's High
¥1,444
Day's Low
¥1,418
Volume
9,742,900
Avg. Vol
7,456,124
52-wk High
¥1,688
52-wk Low
¥1,332

Yasukawa, Kenji 

Mr. Kenji Yasukawa has been serving as Vice President, Chief Strategy Officer, Chief Commercial Officer and Representative Director in Astellas Pharma Inc. since June 19, 2017. He joined the Company in April 1986. His previous titles include Executive Officer, Senior Executive Officer and Director of Product Strategy in the Company. He used to work for Yamanouchi Pharmaceutical Co., Ltd. and a subsidiary.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --